mergers

presented by

What’s the next big biopharma deal? Here are four contenders…

Life sciences M&A activity – and buzz – has hit a fever pitch in the past few months. As the industry braces itself for biosimilars to hit it big and precision medicine to drive development in targeted therapy, even more acquisitions are on the horizon. BioPharma Dive has compiled a tantalizing list of some potential acquisitions: […]